<p>GE HealthCare Technologies（纳斯达克：GEHC - 获取免费报告）在周二发布的研究报告中，阿根廷证券公司的研究人员将其目标价格从 95.00 美元下调至 80.00 美元，MarketScreener 报道。该公司目前对该股票给予 “买入” 评级。阿根廷的价格目标暗示该股票当前价格有 28.92% 的潜在上涨空间。</p>
<ul>
<li>GE 航空：卡塔尔交易推动数十亿美元的增长引擎</li>
</ul>
<p>其他几家股票研究分析师也对 GEHC 发布了报告。摩根大通将 GE HealthCare Technologies 的目标价格从 80.00 美元下调至 65.00 美元，并在 4 月 30 日的研究报告中对该公司给予 “中性” 评级。瑞穗证券在 4 月 30 日的研究报告中将 GE HealthCare Technologies 的目标价格从 90.00 美元下调至 80.00 美元。巴黎银行 Exane 在 5 月 1 日的研究报告中将 GE HealthCare Technologies 的目标价格从 95.00 美元下调至 88.00 美元。Evercore 在 4 月 30 日的研究报告中对 GE HealthCare Technologies 设定了 80.00 美元的目标价格。最后，巴克莱在 4 月 30 日的研究报告中将 GE HealthCare Technologies 的目标价格从 87.00 美元下调至 78.00 美元，并对该股票给予 “等权重” 评级。九位研究分析师对该股票给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，GE HealthCare Technologies 的平均评级为 “持有”，平均目标价格为 80.63 美元。</p>
<p><strong>获取我们关于 GEHC 的最新报告</strong></p>
<h2>GE HealthCare Technologies 股票上涨 0.9%</h2>
<ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
<p>在周二的交易中，GEHC 上涨 0.54 美元，达到 62.05 美元。该公司股票的交易量为 1,765,974 股，而其平均交易量为 4,147,691 股。该股票的市值为 282.3 亿美元，市盈率为 14.89，市盈增长比率为 1.37，贝塔值为 0.74。该公司的 50 日移动平均线为 69.27 美元，200 日移动平均线为 76.59 美元。GE HealthCare Technologies 的 52 周低点为 58.75 美元，52 周高点为 89.77 美元。该公司的速动比率为 0.95，流动比率为 1.22，债务与股本比率为 0.95。</p>
<p>GE HealthCare Technologies（纳斯达克：GEHC - 获取免费报告）最后一次发布财报是在 4 月 29 日，周三。该公司报告季度每股收益为 0.99 美元，低于分析师一致预期的 1.07 美元，差距为 0.08 美元。该公司在本季度的收入为 51.3 亿美元，而分析师预期为 50.4 亿美元。GE HealthCare Technologies 的股本回报率为 20.46%，净利润率为 9.10%。该公司的收入同比增长 7.4%。在去年同期，该公司每股收益为 1.01 美元。GE HealthCare Technologies 已将其 2026 财年的指导目标设定为 4.800-5.000 美元每股收益。整体来看，股票分析师预计 GE HealthCare Technologies 在当前财年将发布 4.89 美元的每股收益。</p>
<h2>GE HealthCare Technologies 的内部买卖情况</h2>
<ul>
<li>超声波减肥：GE HealthCare 和诺和诺德的合作</li>
</ul>
<p>在其他新闻中，内部人士 Frank R. Jimenez 在 4 月 30 日的交易中购买了 1,750 股该公司的股票。股票的平均购买价格为每股 60.45 美元，总价值为 105,787.50 美元。购买后，该内部人士持有 93,932 股公司股票，价值约为 5,678,189.40 美元。这笔交易代表其持股比例增加了 1.90%。该购买在 SEC 的法律文件中披露，相关信息可在 SEC 网站上找到。此外，董事 Rodney F. Hochman 在 5 月 12 日的交易中购买了 1,618 股该股票。股票的平均购买价格为每股 62.03 美元，总交易额为 100,364.54 美元。交易完成后，该董事在公司持有 1,618 股，价值约为 100,364.54 美元。这代表其持股比例的∞增长。该购买的 SEC 文件提供了更多信息。在过去的一个季度中，内部人士购买了 11,847 股公司股票，价值 719,555 美元。公司内部人士持有该公司股票的 0.36%。</p>
<h2>对 GE HealthCare Technologies 的对冲基金看法</h2>
<p>机构投资者和对冲基金最近买卖了该公司的股票。Laurel Wealth Advisors LLC 在第四季度购买了 GE HealthCare Technologies 的新头寸，价值约 26,000 美元。Optima Capital LLC 在第四季度收购了 GE HealthCare Technologies 的新头寸，价值约 27,000 美元。Godfrey Financial Associates Inc.在第四季度收购了 GE HealthCare Technologies 的新股份，价值约 27,000 美元。Montag A &amp; Associates Inc.在第四季度将其在 GE HealthCare Technologies 的持股增加了 105.4%。Montag A &amp; Associates Inc.现在持有 341 股该公司的股票，价值 28,000 美元，此前在上个季度又购买了 175 股。最后，Transamerica Financial Advisors LLC 在第四季度将其在 GE HealthCare Technologies 的持股增加了 331.6%。Transamerica Financial Advisors LLC 现在持有 341 股该公司的股票，价值 28,000 美元，此前在上个季度又收购了 262 股。对冲基金和其他机构投资者持有该公司 82.06% 的股票。</p>
<h2>GE HealthCare Technologies 公司简介</h2>
<p>（获取免费报告）</p>
<p>GE HealthCare Technologies 纳斯达克股票代码：GEHC 是一家全球医疗技术和诊断公司，开发、制造并销售广泛的产品和服务，服务于医疗提供者。其产品组合以诊断成像系统为中心，包括 MRI、CT、PET 和 X 射线设备，以及超声设备。该公司还提供患者监测和麻醉输送系统、介入和外科成像解决方案，以及用于临床护理和研究环境的分子成像技术。</p>
<p>除了硬件，GE HealthCare 还提供旨在改善临床工作流程和设备正常运行时间的软件、分析和生命周期服务。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比 GE HealthCare Technologies 更好的股票</li>
<li>Nebius Group 在强劲收益后被下调评级，股价回落 9%</li>
<li>重塑人工智能：NextEra Energy 引发大规模合并</li>
<li>切换开关：福特会是下一个大能源股票吗？</li>
<li>Nano Nuclear Energy 的新交易是否提升了前景？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
<p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 GE HealthCare Technologies 并不在名单上。</p>
<p>虽然 GE HealthCare Technologies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

GEHC

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

<p>阿根廷分析师将 GE HealthCare Technologies（NASDAQ:GEHC）的目标股价从 95.00 美元下调至 80.00 美元，维持 “买入” 评级。摩根大通和瑞穗等其他公司也调整了他们的目标价，摩根大通将其设定为 65.00 美元。目前，GEHC 的股票交易价格为 62.05 美元，分析师的平均目标价为 80.63 美元。该公司报告每股收益为 0.99 美元，未达到预期，但收入同比增长了 7.4%</p>

<p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) had its target price lowered by equities researchers at Argus from $95.00 to $80.00 in a research note issued on Tuesday,MarketScreener reports. The firm presently has a &#34;buy&#34; rating on the stock. Argus' price objective would suggest a potential upside of 28.92% from the stock's current price.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（纳斯达克：GEHC - 获取免费报告）在周二发布的研究报告中，阿根廷证券公司的研究人员将其目标价格从 95.00 美元下调至 80.00 美元，MarketScreener 报道。该公司目前对该股票给予 “买入” 评级。阿根廷的价格目标暗示该股票当前价格有 28.92% 的潜在上涨空间。</p>
</div><ul>
<li>GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>GE 航空：卡塔尔交易推动数十亿美元的增长引擎</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on GEHC. JPMorgan Chase &amp; Co. cut their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a &#34;neutral&#34; rating for the company in a research note on Thursday, April 30th. Mizuho reduced their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Evercore set a $80.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Barclays dropped their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an &#34;equal weight&#34; rating on the stock in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of &#34;Hold&#34; and an average price target of $80.63.</p>
<div class="lb-trans"><p>其他几家股票研究分析师也对 GEHC 发布了报告。摩根大通将 GE HealthCare Technologies 的目标价格从 80.00 美元下调至 65.00 美元，并在 4 月 30 日的研究报告中对该公司给予 “中性” 评级。瑞穗证券在 4 月 30 日的研究报告中将 GE HealthCare Technologies 的目标价格从 90.00 美元下调至 80.00 美元。巴黎银行 Exane 在 5 月 1 日的研究报告中将 GE HealthCare Technologies 的目标价格从 95.00 美元下调至 88.00 美元。Evercore 在 4 月 30 日的研究报告中对 GE HealthCare Technologies 设定了 80.00 美元的目标价格。最后，巴克莱在 4 月 30 日的研究报告中将 GE HealthCare Technologies 的目标价格从 87.00 美元下调至 78.00 美元，并对该股票给予 “等权重” 评级。九位研究分析师对该股票给予 “买入” 评级，八位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，GE HealthCare Technologies 的平均评级为 “持有”，平均目标价格为 80.63 美元。</p>
</div><p><strong>Get Our Latest Report on GEHC</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 GEHC 的最新报告</strong></p>
</div><h2>GE HealthCare Technologies Stock Up 0.9%</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 股票上涨 0.9%</h2>
</div><ul>
<li>Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>霍尼韦尔的拆分：HON 股票对投资者来说是个好交易吗？</li>
</ul>
</div><p>GEHC traded up $0.54 during trading on Tuesday, hitting $62.05. 1,765,974 shares of the company's stock were exchanged, compared to its average volume of 4,147,691. The stock has a market cap of $28.23 billion, a P/E ratio of 14.89, a PEG ratio of 1.37 and a beta of 0.74. The business's 50 day moving average is $69.27 and its two-hundred day moving average is $76.59. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.</p>
<div class="lb-trans"><p>在周二的交易中，GEHC 上涨 0.54 美元，达到 62.05 美元。该公司股票的交易量为 1,765,974 股，而其平均交易量为 4,147,691 股。该股票的市值为 282.3 亿美元，市盈率为 14.89，市盈增长比率为 1.37，贝塔值为 0.74。该公司的 50 日移动平均线为 69.27 美元，200 日移动平均线为 76.59 美元。GE HealthCare Technologies 的 52 周低点为 58.75 美元，52 周高点为 89.77 美元。该公司的速动比率为 0.95，流动比率为 1.22，债务与股本比率为 0.95。</p>
</div><p>GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts expect that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>GE HealthCare Technologies（纳斯达克：GEHC - 获取免费报告）最后一次发布财报是在 4 月 29 日，周三。该公司报告季度每股收益为 0.99 美元，低于分析师一致预期的 1.07 美元，差距为 0.08 美元。该公司在本季度的收入为 51.3 亿美元，而分析师预期为 50.4 亿美元。GE HealthCare Technologies 的股本回报率为 20.46%，净利润率为 9.10%。该公司的收入同比增长 7.4%。在去年同期，该公司每股收益为 1.01 美元。GE HealthCare Technologies 已将其 2026 财年的指导目标设定为 4.800-5.000 美元每股收益。整体来看，股票分析师预计 GE HealthCare Technologies 在当前财年将发布 4.89 美元的每股收益。</p>
</div><h2>Insider Buying and Selling at GE HealthCare Technologies</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 的内部买卖情况</h2>
</div><ul>
<li>Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play</li>
</ul>
<div class="lb-trans"><ul>
<li>超声波减肥：GE HealthCare 和诺和诺德的合作</li>
</ul>
</div><p>In other news, insider Frank R. Jimenez acquired 1,750 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider owned 93,932 shares of the company's stock, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Rodney F. Hochman acquired 1,618 shares of the stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the transaction, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 11,847 shares of company stock valued at $719,555. Corporate insiders own 0.36% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，内部人士 Frank R. Jimenez 在 4 月 30 日的交易中购买了 1,750 股该公司的股票。股票的平均购买价格为每股 60.45 美元，总价值为 105,787.50 美元。购买后，该内部人士持有 93,932 股公司股票，价值约为 5,678,189.40 美元。这笔交易代表其持股比例增加了 1.90%。该购买在 SEC 的法律文件中披露，相关信息可在 SEC 网站上找到。此外，董事 Rodney F. Hochman 在 5 月 12 日的交易中购买了 1,618 股该股票。股票的平均购买价格为每股 62.03 美元，总交易额为 100,364.54 美元。交易完成后，该董事在公司持有 1,618 股，价值约为 100,364.54 美元。这代表其持股比例的∞增长。该购买的 SEC 文件提供了更多信息。在过去的一个季度中，内部人士购买了 11,847 股公司股票，价值 719,555 美元。公司内部人士持有该公司股票的 0.36%。</p>
</div><h2>Hedge Funds Weigh In On GE HealthCare Technologies</h2>
<div class="lb-trans"><h2>对 GE HealthCare Technologies 的对冲基金看法</h2>
</div><p>Institutional investors and hedge funds have recently bought and sold shares of the business. Laurel Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $26,000. Optima Capital LLC acquired a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Montag A &amp; Associates Inc. increased its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A &amp; Associates Inc. now owns 341 shares of the company's stock worth $28,000 after buying an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC raised its position in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company's stock worth $28,000 after acquiring an additional 262 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近买卖了该公司的股票。Laurel Wealth Advisors LLC 在第四季度购买了 GE HealthCare Technologies 的新头寸，价值约 26,000 美元。Optima Capital LLC 在第四季度收购了 GE HealthCare Technologies 的新头寸，价值约 27,000 美元。Godfrey Financial Associates Inc.在第四季度收购了 GE HealthCare Technologies 的新股份，价值约 27,000 美元。Montag A &amp; Associates Inc.在第四季度将其在 GE HealthCare Technologies 的持股增加了 105.4%。Montag A &amp; Associates Inc.现在持有 341 股该公司的股票，价值 28,000 美元，此前在上个季度又购买了 175 股。最后，Transamerica Financial Advisors LLC 在第四季度将其在 GE HealthCare Technologies 的持股增加了 331.6%。Transamerica Financial Advisors LLC 现在持有 341 股该公司的股票，价值 28,000 美元，此前在上个季度又收购了 262 股。对冲基金和其他机构投资者持有该公司 82.06% 的股票。</p>
</div><h2>GE HealthCare Technologies Company Profile</h2>
<div class="lb-trans"><h2>GE HealthCare Technologies 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.</p>
<div class="lb-trans"><p>GE HealthCare Technologies 纳斯达克股票代码：GEHC 是一家全球医疗技术和诊断公司，开发、制造并销售广泛的产品和服务，服务于医疗提供者。其产品组合以诊断成像系统为中心，包括 MRI、CT、PET 和 X 射线设备，以及超声设备。该公司还提供患者监测和麻醉输送系统、介入和外科成像解决方案，以及用于临床护理和研究环境的分子成像技术。</p>
</div><p>In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.</p>
<div class="lb-trans"><p>除了硬件，GE HealthCare 还提供旨在改善临床工作流程和设备正常运行时间的软件、分析和生命周期服务。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than GE HealthCare Technologies</li>
<li>Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings</li>
<li>Rewiring AI: NextEra Energy Sparks a Mega Merger</li>
<li>Flipping the Switch: Is Ford the Next Big Energy Stock?</li>
<li>Does Nano Nuclear Energy’s New Deal Amp the Outlook?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 GE HealthCare Technologies 更好的股票</li>
<li>Nebius Group 在强劲收益后被下调评级，股价回落 9%</li>
<li>重塑人工智能：NextEra Energy 引发大规模合并</li>
<li>切换开关：福特会是下一个大能源股票吗？</li>
<li>Nano Nuclear Energy 的新交易是否提升了前景？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0VIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=GEHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in GE HealthCare Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 GE HealthCare Technologies 吗？</h2>
</div><p>Before you consider GE HealthCare Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 GE HealthCare Technologies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 GE HealthCare Technologies 并不在名单上。</p>
</div><p>While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 GE HealthCare Technologies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

GE HealthCare Technologies (NASDAQ:GEHC) Price Target Cut to $80.00 by Analysts at Argus

Market Beat

GE HealthCare Tech

摩根大通

瑞穗金融集团

Mizuho Financial Group, Inc.

法国巴黎银行(ADR)

Evercore

巴克莱银行

GE航空航天

霍尼韦尔

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Honeywell International - WI

Argus 的分析师将 GE HealthCare Technologies（NASDAQ:GEHC）的目标股价下调至 80.00 美元